Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The use of electronic medical records (EMRs) has increased dramatically over the last 15 years. However, psychiatry has lagged. EMRs are not being used by many mental health professionals. There are many reasons, including financial burden, lack of technological support, stigma, disaggregation of upfront costs, indirect benefits, and concerns about privacy and Health Insurance Portability and Accountability Act compliance. Obtaining paper records is a lengthy process, making continuity of care and emergency care challenging. Even when records are made available, it is common for information to be incomplete. The objective of this article is to highlight how the continued use of paper charts may decrease the quality and timeliness of psychiatric care provided and to discuss the psychiatry-specific issues created by EMRs. A case illustrating the disruption of care by continued use of paper charts in psychiatric facilities is presented. The growing use of EMR creates new challenges that affect psychiatry in ways other fields are not affected. These challenges include confidentiality issues, the frequent change/spectrum of diagnoses, determining how much information should be recorded in a note, and what the implications are of the information recorded. This article will discuss the use of EMRs in psychiatry, as well as encourage medical students and residents to take a deeper dive into psychiatry-specific issues regarding the use of EMR. EMR use may have a profound impact on our patient outcomes, health care delivery system, shorter inpatient stay, as well as reduce health care costs.

Download full-text PDF

Source
http://dx.doi.org/10.1097/NMD.0000000000001606DOI Listing

Publication Analysis

Top Keywords

paper charts
12
psychiatric care
8
mental health
8
continued paper
8
psychiatry-specific issues
8
health care
8
care
7
health
5
paper
4
charts continued
4

Similar Publications

Treatment and Referral of Youth with Opioid Addiction in the Pediatric Emergency Department: A Pilot Study.

Acad Pediatr

September 2025

Division of Emergency and Transport Medicine, Children's Hospital Los Angeles, Los Angeles, California; Department of Pediatrics, Keck School of Medicine of the University of Southern California, Los Angeles, California. Electronic address:

Background: Fatal opioid overdoses have increased among adolescents. Emergency Departments (EDs) are critical access points for connecting adults with opioid use disorder (OUD) to medication-assisted treatment (MAT). Whether this is feasible in pediatric patients is unknown.

View Article and Find Full Text PDF

Degree of food processing and incidence of obesity-related cancers in the 'Seguimiento Universidad de Navarra' (SUN) Project.

J Nutr

September 2025

Department of Preventive Medicine and Public Health, CCUN, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain; Biomedical Research Centre Network on Obesity and Nutrition (CIBERobn), Spanish National Institute of Health Carlos III, Avda. Monforte de Lemos, 3-5, 28029 Madrid, Spain; IdiSNA, N

Background: The prevalence of obesity and associated diseases, including several cancers, continues to rise.

Objective: Given the growing evidence that the degree of food processing impacts health, we investigated the relationship between the degree of food processing and the risk of obesity-related cancers (ORC).

Methods: We analyzed data from 17,756 participants in the "Seguimiento Universidad de Navarra" (SUN) project, a prospective cohort of Spanish graduates.

View Article and Find Full Text PDF

Clinical implementation and outcome evaluation of dihydropyrimidine dehydrogenase (DPYD) pharmacogenomic testing for fluoropyrimidine dosing in a Canadian Provincial Healthcare center.

Clin Biochem

September 2025

Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E6, Canada; Department of Pathology and Laboratory Medicine, Saskatchewan Health Authority, Saskatoon, SK S7M 0Z9, Canada. Electronic address:

Background: 5-Fluorouracil (5-FU) and its pro-drug, capecitabine, are widely used to treat solid tumors. Patients with dihydropyrimidine dehydrogenase (DPYD) deficiency are at increased risk for severe treatment-related toxicity. This study reported the implementation of DPYD genotyping in clinical practice and assessed the impact of genotype-guided dosing on clinical outcomes.

View Article and Find Full Text PDF

Current approaches used for pediatric liver transplant (LT) surveillance have diagnostic limitations. We used pleximmune™ immune reactivity index (IRI) and anti-HLA donor specific antibody (DSA) to predict the adequacy of immunosuppression (IS) relative to risk of acute cellular rejection (ACR) at 1-year post LT. This is a retrospective chart review of children who underwent LT between January 1, 2016, through December 31, 2020, and had at least one pleximmune measurement performed within 60-days of a liver biopsy.

View Article and Find Full Text PDF

Chimeric antigen receptor (CAR) T-cell therapy has changed how we treat blood cancers but hasn't worked as well for solid tumors like pancreatic ductal adenocarcinoma (PDAC), mainly because these tumors are very aggressive and resistant to regular treatments. This review critically examines peer-reviewed studies to chart the evolution of immunotherapy in PDAC, emphasizing the unique barriers to effective CAR T-cell treatment and emerging strategies to overcome them. CAR T-cells that focus on tumor-related markers like mesothelin, HER2, and MUC1 have shown promise in early research models.

View Article and Find Full Text PDF